Industry: Drug Manufacturers Major
Shire PLC- (SHPGY)-focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
© 2020  Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.
SHPG Payout History (Paid and Declared)
|Year||Calendar Year Payout||Calendar Year Payout Growth||Pay Date||Declared Date||Ex-Dividend Date||Payout Amount||Qualified Dividend?||Payout Type||Frequency||Days Taken For Stock Price To Recover|